BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 32013725)

  • 1. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
    Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
    Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case series of three adult patients with exceptional clinical presentations of haemophagocytic lymphohistiocytosis.
    Khairoun M; Meynen F; Vercoutere W; Leavis HL
    Neth J Med; 2020 Apr; 78(3):136-141. PubMed ID: 32332189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
    Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
    Ohmura SI; Uehara K; Yamabe T; Tamechika S; Maeda S; Naniwa T
    Mod Rheumatol Case Rep; 2020 Jul; 4(2):202-207. PubMed ID: 33086994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
    Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
    Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis.
    Félix FH; Leal LK; Fontenele JB
    Rheumatol Int; 2009 Jun; 29(8):973-4. PubMed ID: 19115058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
    Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
    J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.
    Wang R; Li T; Ye S; Lv L; Chen S; Wang X; Bao CD; Fu Q
    Clin Rheumatol; 2022 Sep; 41(9):2817-2823. PubMed ID: 35590113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
    Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
    Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP).
    Sandler RD; Tattersall RS; Schoemans H; Greco R; Badoglio M; Labopin M; Alexander T; Kirgizov K; Rovira M; Saif M; Saccardi R; Delgado J; Peric Z; Koenecke C; Penack O; Basak G; Snowden JA
    Front Immunol; 2020; 11():524. PubMed ID: 32296434
    [No Abstract]   [Full Text] [Related]  

  • 15. Biallelic mutations in the CFHR genes underlying atypical hemolytic uremic syndrome in a patient with catastrophic adult-onset Still's disease and recurrent macrophage activation syndrome: A case report.
    Dillemans L; Bekhuis Y; Betrains A; Yu K; van Hemelen M; Pörtner N; De Somer L; Matthys P; Breckpot J; Tousseyn T; Peetermans M; Proost P; Wouters C; Vanderschueren S
    Clin Immunol; 2023 Dec; 257():109815. PubMed ID: 37898413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome.
    Gianella S; Schaer DJ; Schwarz U; Kurrer M; Heppner FL; Fehr J; Seebach JD
    Am J Hematol; 2008 May; 83(5):424-7. PubMed ID: 18183612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.
    Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P
    Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease.
    Park JH; Kim SH; Kim HJ; Lee SJ; Jeong DC; Kim SY
    J Perinatol; 2015 Feb; 35(2):158-60. PubMed ID: 25627282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
    Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
    Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of glucocorticoid and cyclosporine refractory adult-onset Still's disease complicated with hemophagocytic syndrome with plasma exchange therapy and tocilizumab : a case report.
    Komiya Y; Takenaka K; Nagasaka K
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(6):478-83. PubMed ID: 24390109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.